Patients with underlying irritable bowel disease (IBD) have an increased risk of developing potentially severe gastrointestinal (GI) adverse events during immune checkpoint inhibitor therapy compared with patients without IBD, according to the results of an international, multicenter, retrospective study. The findings were published in the Journal of Clinical Oncology.1 The study included 102 retrospectively identified patients with IBD who were treated with an immune checkpoint inhibitor between January 2010 and February 2019 as a well as 11,377 patients without IBD to serve as a comparator group Continue reading →

The US House this morning passed the PFAS Action Act, 247-159, which would strengthen the nearly non-existent regulations for toxic perfluorinated compounds. Continue reading →

Tommy Joyce is no cinephile. Continue reading →

Innovation Wellness, located at 111 South Barron St., opened this past fall, ready to offer the community alternative solutions to their ailments. EATON Innovation Wellness, located at 111 South Barron St., opened this past fall, ready to offer the community alternative solutions to their ailments. Continue reading →

A fresh market research study titled Global Ulcerative Colitis Market explores several significant facets related to Ulcerative Colitis Market covering industry environment, segmentation analysis, and competitive landscape. Realistic concepts of the market are mentioned in a simple and plain manner in this report. A comprehensive and elaborate primary analysis report highlights numerous facts such as development factors, business enhancement strategies, statistical growth, financial gain or loss to help readers and clients to understand the market on a global scale Continue reading →

ReportsnReports has recently added a new research report to its expanding repository. The research report, titled Ulcerative Colitis Market, offers a clear understanding of the subject matter. Continue reading →

SAN DIEGO, Jan. Continue reading →

The Ulcerative ColitisMarketreport focus on the current trends of the market along with detailed analysis which provides data regarding this market rate, and it also predicts the future market growth rate. The Ulcerative Colitis Market study includes research on the top markets based on all the data from the elite players, current, past and future. Major companies in the Ulcerative Colitis were identified through the second survey and market share was determined through the first and second surveys. Continue reading →

Mabpharm has filed an application with Chinas National Medical Products Administration (NMPA) seeking approval of a biobetter of infliximab, a biological treatment for people with ankylosing spondylitisand other inflammatory disorders. Sorrento Therapeutics, the company owning global rights to the biobetter antibody outside of China, plans to file a biologics license application in the United States for the same purpose. Continue reading →